RxDoctor Payments DataLook up a doctor →

Leonard Zemel

Endocrinology, Diabetes & Metabolism · Denver, CONPI 1447256045

Payments from drug & device makers

$727,602in general payments, 2019–2025

Across 2,436 payments — averaging $298.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk AS$409K
  • AbbVie$171K
  • Gilead$44K
  • AstraZeneca$43K
  • Boehringer Ingelheim$35K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$5K
  • plus $19K from 36 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$727,602 in reported general payments places this provider in the 90th percentile of 120 endocrinology, diabetes & metabolism providers in Colorado.

See all endocrinology, diabetes & metabolism providers in Colorado

Other endocrinology, diabetes & metabolism in Denver

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →